Central Nervous System Nanomedicines Market Size to Reach USD 2.38 Billion by 2031
Global Central Nervous System Nanomedicines market is undergoing a rapid transformation as nanotechnology reshapes the way neurological disorders are diagnosed and treated. Valued at USD 1.04 billion in 2024, the market is projected to reach USD 2.38 billion by 2031, expanding at a strong CAGR of 13.3% during the forecast period. Growth is driven by rising prevalence of neurological disorders,...
0 Comentários 0 Compartilhamentos 45 Visualizações 0 Anterior